Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression

Autoimmunity and cancer rates have both been on the rise in Western civilization prompting many to investigate the link between the two entities. This review will investigate the complex interactions between the activation and deactivation of the immune system and the development of malignancy. Additional focus will be placed on the main classes of immune inhibitor therapy utilized in transplant patients and in autoimmune disease including TNF-alpha, Calcineurin, mTOR, purine synthesis antagonists and IMPDH inhibitors.

Automated summary

This review examines the complex interactions between immune system activation and deactivation and the development of malignant tumors, as well as the link between autoimmunity and cancer rates. Furthermore, it focuses on the main classes of immune inhibitor therapy used in transplant patients and in autoimmune diseases, such as TNF-alpha, Calcineurin, mTOR, purine synthesis antagonists, and IMPDH inhibitors.